# FDA recall D-0364-2024

> **Contract Pharmaceuticals Limited Canada** · Class III · drug recall initiated 2024-02-20.

## Product

Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61

## Reason for recall

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

## Distribution

Nationwide in the U.S. and Puerto Rico

## Key facts

- **Recall number:** D-0364-2024
- **Recalling firm:** Contract Pharmaceuticals Limited Canada
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-02-20
- **Report date:** 2024-03-13

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Mississauga, Canada

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0364-2024

## Citation

> AI Analytics. FDA recall D-0364-2024. Retrieved 2026-07-20 from https://api.ai-analytics.org/recall/D-0364-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*